Skip to content
Frisco News

Novo Nordisk sues rival Eli Lilly over ‘misleading' weight-loss drug advertising

Novo Nordisk sues rival Eli Lilly over ‘misleading' weight-loss drug advertising
Photo: NBC 5 Dallas-Fort Worth (KXAS) - Top Stories · view original

Two of the world’s biggest pharmaceutical companies are headed to court after Novo Nordisk, the maker of Ozempic and a pioneer in diabetes and obesity treatments, sued rival Eli Lilly on Tuesday, accusing the U.S. drugmaker of false advertising. The Danish company filed the lawsuit in U.S. Distr...

Sources and story details